...
首页> 外文期刊>Evidence-based complementary and alternative medicine: eCAM >The Herbal Formula Granule Prescription Mahuang Decoction Ameliorated Chronic Kidney Disease Which Was Associated with Restoration of Dysbiosis of Intestinal Microbiota in Rats
【24h】

The Herbal Formula Granule Prescription Mahuang Decoction Ameliorated Chronic Kidney Disease Which Was Associated with Restoration of Dysbiosis of Intestinal Microbiota in Rats

机译:草药颗粒处方麻发汤改善慢性肾病与大鼠肠道微生物缺陷的恢复相关

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Chronic kidney disease (CKD) has become a global health issue, and there is increasing evidence showing the beneficial roles of traditional Chinese medicine (TCM) in CKD treatment. Here, we studied the renoprotective role of Mahuang decoction, a famous TCM prescription, in a rat CKD model induced with the combination of doxorubicin and adenine. Our data showed that intragastric administration of Mahuang decoction inhibited the loss of bodyweight and attenuated proteinuria, serum creatinine, and blood urea nitrogen in CKD rats. Kidney histological analysis revealed decreased tubulointerstitial injury and fibrosis in CKD rats treated with Mahuang decoction accompanied with suppressed expression of TGF- β 1 and phosphorylated NF- κ B/P65 (p-P65) as indicated by immunohistochemistry. ELISA analysis demonstrated reduced serum levels of proinflammatory cytokines TNF α and IL-6. Most importantly, intestinal microbiota analysis by 16s rRNA-seq showed that Mahuang decoction restored the impaired richness and diversity of intestinal microflora and recovered the disrupted microbial community through reducing the abundance of deleterious microbes and promoting the expansion of beneficial microbes in CKD rats. Collectively, our findings demonstrated that Mahuang decoction mitigated kidney functional and structural impairment in CKD rats which were associated with the restoration of dysbiosis of intestinal microbiota, implying its potential in clinical CKD treatment.
机译:慢性肾病(CKD)已成为全球卫生问题,越来越多的证据表明中药(TCM)在CKD治疗中的有益作用。在这里,我们研究了汉普汤,着名的中医处方,在诱导的多柔比星和腺嘌呤组合诱导的大鼠CKD模型中的重新调试作用。我们的数据显示,胃肠汤的胃内给药抑制了CKD大鼠体重和减毒蛋白尿,血清肌酐和血尿尿素氮的损失。肾组织学分析显示,随着免疫组织化学所示,伴随着抑制TGF-β1和磷酸化NF-κB/ P65(P-P65)的抑制表达,伴随着Mahuang煎剂治疗的CKD大鼠的细胞间失调损伤和纤维化。 ELISA分析证明了血清血清血清α和IL-6水平降低。最重要的是,肠道微生物群分析16S RRNA-SEQ表明,Mahuang汤恢复了肠道微生物的丰富性和多样性受损,并通过减少有害微生物的丰度并促进CKD大鼠的有益微生物的扩张来回收破坏的微生物群落。统称,我们的研究结果表明,与肠道微生物遗传症恢复有关的CKD大鼠中的麻黄汤中的肾功能和结构损伤,暗示其在临床CKD治疗中的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号